SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-005914
Filing Date
2021-05-05
Accepted
2021-05-05 16:08:06
Documents
73
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ocul-20210331x10q.htm   iXBRL 10-Q 1851349
2 EX-31.1 ocul-20210331xex31d1.htm EX-31.1 12006
3 EX-31.2 ocul-20210331xex31d2.htm EX-31.2 8446
4 EX-32.1 ocul-20210331xex32d1.htm EX-32.1 4989
5 EX-32.2 ocul-20210331xex32d2.htm EX-32.2 4970
  Complete submission text file 0001558370-21-005914.txt   6027672

Data Files

Seq Description Document Type Size
6 EX-101.SCH ocul-20210331.xsd EX-101.SCH 43525
7 EX-101.CAL ocul-20210331_cal.xml EX-101.CAL 50105
8 EX-101.DEF ocul-20210331_def.xml EX-101.DEF 131090
9 EX-101.LAB ocul-20210331_lab.xml EX-101.LAB 329360
10 EX-101.PRE ocul-20210331_pre.xml EX-101.PRE 278979
11 EXTRACTED XBRL INSTANCE DOCUMENT ocul-20210331x10q_htm.xml XML 861844
Mailing Address 24 CROSBY DRIVE BEDFORD MA 01730
Business Address 24 CROSBY DRIVE BEDFORD MA 01730 781-895-3235
OCULAR THERAPEUTIX, INC (Filer) CIK: 0001393434 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36554 | Film No.: 21893277
SIC: 2834 Pharmaceutical Preparations